The use of Janus kinase inhibitors to treat noninfectious uveitis
Jakinibs may have a role in treatment of refractory noninfectious uveitis after failing conventional IMT. Both Jakinibs were well tolerated with a low incidence of side effects.
Authors
- Sumit Sharma (ORCID: https://orcid.org/0000-0001-5769-0717)
- Careen Y. Lowder (ORCID: https://orcid.org/0000-0001-6723-7238)
- Ashley Lowe
- Madeline Beckman (ORCID: https://orcid.org/0000-0002-0283-8902)
- Sunil K. Srivastava
- Kim Baynes
Institutions
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Cleveland Eye Clinic (US)
Publication Details
- Journal
- Eye
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1038/s41433-025-04065-w
- Citations
- 1
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.71